BRCA2 and cancer: For Latin American populations, while BRCA1 and BRCA2 PVs are well-known in hereditary breast and ovarian cancer syndrome (HBOC) [3–6], other HCS associated with risks for cancers beyond breast and ovarian are less well-characterized.